Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study

Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathies

Allen, Jeffrey A.
Berger, Melvin
Querol, Luis
Kuitwaard, Krista
Hadden, Robert D.
Universitat Autònoma de Barcelona

Despite the well-recognized importance of immunoglobulin therapy individualization during the treatm...

Optimizing chronic inflammatory demyelinating polyneuropathy care with subcutaneous immunoglobulin: The Polyneuropathy and Treatment with Hizentra Open-Label Extension (PATH OLE) study and beyond

Mazen M. Dimachkie

June 2022

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous, acquired autoimmune neu...

Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy

Min-Suk Yoon
Andrew Chan
Ralf Gold

May 2011

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated polyradicul...

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Schaik, I.N. van
Bril, V.
Geloven, N. van
Hartung, H.P.
Lewis, R.A.
Sobue, G.
Lawo, J.P.
Praus, M.
Mielke, O.
Durn, B.L.
Cornblath, D.R.
Merkies, I.S.J.
PATH Study Grp

January 2018

Development and application of statistical models for medical scientific researc

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

Schaik, I.N. van
Geloven, N. van
Bril, V.
Hartung, H.P.
Lewis, R.A.
Sobue, G.
Lawo, J.P.
Mielke, O.
Comblath, D.R.
Merkies, I.S.J.
PATH Study Grp

July 2016

Development and application of statistical models for medical scientific researc

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study

Dario Cocito
Aristide Merola
Erdita Peci
Anna Mazzeo
Raffaella Fazio
Ada Francia
Paola Valentino
Rocco Liguori
Massimiliano Filosto
Gabriele Siciliano
Angelo Maurizio Clerici
Stefania Lelli
Girolama Alessandra Marfia
Giovanni Antonini
Ilaria Cecconi
Eduardo Nobile-Orazio
Leonardo Lopiano
Italian Network Scig And chronic Dysimmune Neuropathies

January 2014

This multi-center Italian prospective observational study reports the 4 months follow-up data of 87 ...

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

D. Cocito
A. Merola
E. Peci
A. Mazzeo
R. Fazio
A. Francia
P. Valentino
M. Filosto
G. Siciliano
A. M. Clerici
S. Lelli
G. A. Marfia
G. Antonini
I. Cecconi
E. Nobile Orazio
L. Lopiano
S. C. Ig
LIGUORI, ROCCO

January 2014

This multi-center Italian prospective observational study reports the 4 months follow-up data of 87 ...

Subcutaneous immunoglobulin in CIDP and MMN : a short-term nationwide study

M. Cocito D
E. Peci
A. Toscano
R. Fazio
A. Francia
P. Valentino
R. Liguori
M. Filosto
G. Siciliano
G. Bono
S. Lelli
G. Marfia
G. Antonini
I. Cecconi
E. Nobile-Orazio
L. Lopiano
SCIg and Chronic Dysimmune Neuropathies Italian Network

January 2014

This multi-center Italian prospective observational study reports the 4 months follow-up data of 87 ...

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH). a randomised, double-blind, placebo-controlled, phase 3 trial

van Schaik, Ivo N
Bril, Vera
van Geloven, Nan
Hartung, Hans-Peter
Lewis, Richard A
Sobue, Gen
Lawo, John-Philip
Praus, Michaela
Mielke, Orell
Durn, Billie L
Cornblath, David R
Merkies, Ingemar S J
Sabet, A.
George, K.
Roberts, L.
Carne, R.
Blum, S.
Henderson, R.
Van Damme, P.
Demeestere, J.
Larue, S.
D'Amour, C.
Bril, V.
Breiner, A.
Kunc, P.
Valis, M.
Sussova, J.
Kalous, T.
Talab, R.
Bednar, M.
Toomsoo, T.
Rubanovits, I.
Gross-Paju, K.
Sorro, U.
Saarela, M.
Auranen, M.
Pouget, J.
Attarian, S.
Le Masson, G.
Wielanek-Bachelet, A.
Desnuelle, C.
Delmont, E.
Clavelou, P.
Aufauvre, D.
Schmidt, J.
Zschuentssch, J.
Sommer, C.
Kramer, D.
Hoffmann, O.
Goerlitz, C.
Haas, J.
Chatzopoulos, M.
Yoon, R.
Gold, R.
Berlit, P.
Jaspert-Grehl, A.
Liebetanz, D.
Kutschenko, A.
Stangel, M.
Trebst, C.
Baum, P.
Bergh, F.
Klehmet, J.
Meisel, A.
Klostermann, F.
Oechtering, J.
Lehmann, H.
Schroeter, M.
Hagenacker, T.
Mueller, D.
Sperfeld, A.
Bethke, F.
Drory, V.
Algom, A.
Yarnitsky, D.
Murinson, B.
Di Muzio, A.
Ciccocioppo, F.
Sorbi, S.
Mata, S.
Schenone, A.
Grandis, M.
Lauria, G.
Cazzato, D.
Antonini, G.
Morino, S.
Cocito, D.
Zibetti, M.
Yokota, T.
Ohkubo, T.
Kanda, T.
Kawai, M.
Kaida, K.
Onoue, H.
Kuwabara, S.
Mori, M.
Iijima, M.
Ohyama, K.
Baba, M.
Tomiyama, M.
Nishiyama, K.
Akutsu, T.
Yokoyama, K.
Kanai, K.
van Schaik, I. N.
Eftimov, F.
Notermans, N. C.
Visser, N.
Faber, C.
Hoeijmakers, J.
Rejdak, K.
Chyrchel-Paszkiewicz, U.
Casanovas Pons, C.
Alberti Aguiló, M.
Gamez, J.
Figueras, M.
Marquez Infante, C.
Benitez Rivero, S.
Lunn, M.
Morrow, J.
Gosal, D.
Lavin, T.
Melamed, I.
Testori, A.
Ajroud-Driss, S.
Menichella, D.
Simpson, E.
Chi-Ho Lai, E.
Dimachkie, M.
Barohn, R. J.
Beydoun, S.
Johl, H.
Lange, D.
Shtilbans, A.
Muley, S.
Ladha, S.
Freimer, M.
Kissel, J.
Latov, N.
Chin, R.
Ubogu, E.
Mumfrey, S.
Rao, T.
MacDonald, P.
Sharma, K.
Gonzalez, G.
Allen, J.
Walk, D.
Hobson-Webb, L.
Gable, K.

January 2018

Background Approximately two-thirds of patients with chronic inflammatory demyelinating polyneuropat...

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH) : a randomised, double-blind, placebo-controlled, phase 3 trial

van Schaik, Ivo N
Bril, Vera
van Geloven, Nan
Hartung, Hans-Peter
Lewis, Richard A
Sobue, Gen
Lawo, John-Philip
Praus, Michaela
Mielke, Orell
Durn, Billie L
Cornblath, David R
Merkies, Ingemar S J

January 2018

Background Approximately two-thirds of patients with chronic inflammatory demyelinating polyneuropat...

INTRAVENOUS IMMUNOGLOBULIN (IVIG) FOR RESTABILIZATION TREATMENT AFTER IVIG WITHDRAWAL IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP). RESULTS FROM THE PRE-RANDOMIZATION PHASE OF THE PATH STUDY

Mielke, O.
Bril, V.
Geloven, N. van
Hartung, H.P.
Lewis, R.A.
Sobue, G.
Lawo, J.P.
Durn, B.L.
Cornblath, D.R.
Merkies, I.S.J.
Schaik, I.N. van
PATH Study Grp

September 2017

Development and application of statistical models for medical scientific researc

Patient-reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy:the PATH study

Hartung, H. P.
Mallick, R.
Bril, V.
Lewis, R. A.
Sobue, G.
Lawo, J. P.
Mielke, O.
Durn, B. L.
Cornblath, D. R.
Merkies, I. S. J.
van Schaik, I. N.

January 2020

Background and purpose Chronic inflammatory demyelinating polyneuropathy (CIDP) causes weakness whic...

Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective

Dario Cocito
Erdita Peci
Maria Claudia Torrieri
Marinella Clerico

November 2023

The therapeutic administration of subcutaneous immunoglobulin (SCIg) offers various advantages over ...

Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathies

Allen, Jeffrey A.
Berger, Melvin
Querol, Luis
Kuitwaard, Krista
Hadden, Robert D.
Universitat Autònoma de Barcelona

Despite the well-recognized importance of immunoglobulin therapy individualization during the treatm...

Optimizing chronic inflammatory demyelinating polyneuropathy care with subcutaneous immunoglobulin: The Polyneuropathy and Treatment with Hizentra Open-Label Extension (PATH OLE) study and beyond

Mazen M. Dimachkie

June 2022

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous, acquired autoimmune neu...

Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy

Min-Suk Yoon
Andrew Chan
Ralf Gold

May 2011

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated polyradicul...

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Schaik, I.N. van
Bril, V.
Geloven, N. van
Hartung, H.P.
Lewis, R.A.
Sobue, G.
Lawo, J.P.
Praus, M.
Mielke, O.
Durn, B.L.
Cornblath, D.R.
Merkies, I.S.J.
PATH Study Grp

January 2018

Development and application of statistical models for medical scientific researc

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

Schaik, I.N. van
Geloven, N. van
Bril, V.
Hartung, H.P.
Lewis, R.A.
Sobue, G.
Lawo, J.P.
Mielke, O.
Comblath, D.R.
Merkies, I.S.J.
PATH Study Grp

July 2016

Development and application of statistical models for medical scientific researc

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study

Dario Cocito
Aristide Merola
Erdita Peci
Anna Mazzeo
Raffaella Fazio
Ada Francia
Paola Valentino
Rocco Liguori
Massimiliano Filosto
Gabriele Siciliano
Angelo Maurizio Clerici
Stefania Lelli
Girolama Alessandra Marfia
Giovanni Antonini
Ilaria Cecconi
Eduardo Nobile-Orazio
Leonardo Lopiano
Italian Network Scig And chronic Dysimmune Neuropathies

January 2014

This multi-center Italian prospective observational study reports the 4 months follow-up data of 87 ...

Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study.

D. Cocito
A. Merola
E. Peci
A. Mazzeo
R. Fazio
A. Francia
P. Valentino
M. Filosto
G. Siciliano
A. M. Clerici
S. Lelli
G. A. Marfia
G. Antonini
I. Cecconi
E. Nobile Orazio
L. Lopiano
S. C. Ig
LIGUORI, ROCCO

January 2014

This multi-center Italian prospective observational study reports the 4 months follow-up data of 87 ...

Subcutaneous immunoglobulin in CIDP and MMN : a short-term nationwide study

M. Cocito D
E. Peci
A. Toscano
R. Fazio
A. Francia
P. Valentino
R. Liguori
M. Filosto
G. Siciliano
G. Bono
S. Lelli
G. Marfia
G. Antonini
I. Cecconi
E. Nobile-Orazio
L. Lopiano
SCIg and Chronic Dysimmune Neuropathies Italian Network

January 2014

This multi-center Italian prospective observational study reports the 4 months follow-up data of 87 ...

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH). a randomised, double-blind, placebo-controlled, phase 3 trial

van Schaik, Ivo N
Bril, Vera
van Geloven, Nan
Hartung, Hans-Peter
Lewis, Richard A
Sobue, Gen
Lawo, John-Philip
Praus, Michaela
Mielke, Orell
Durn, Billie L
Cornblath, David R
Merkies, Ingemar S J
Sabet, A.
George, K.
Roberts, L.
Carne, R.
Blum, S.
Henderson, R.
Van Damme, P.
Demeestere, J.
Larue, S.
D'Amour, C.
Bril, V.
Breiner, A.
Kunc, P.
Valis, M.
Sussova, J.
Kalous, T.
Talab, R.
Bednar, M.
Toomsoo, T.
Rubanovits, I.
Gross-Paju, K.
Sorro, U.
Saarela, M.
Auranen, M.
Pouget, J.
Attarian, S.
Le Masson, G.
Wielanek-Bachelet, A.
Desnuelle, C.
Delmont, E.
Clavelou, P.
Aufauvre, D.
Schmidt, J.
Zschuentssch, J.
Sommer, C.
Kramer, D.
Hoffmann, O.
Goerlitz, C.
Haas, J.
Chatzopoulos, M.
Yoon, R.
Gold, R.
Berlit, P.
Jaspert-Grehl, A.
Liebetanz, D.
Kutschenko, A.
Stangel, M.
Trebst, C.
Baum, P.
Bergh, F.
Klehmet, J.
Meisel, A.
Klostermann, F.
Oechtering, J.
Lehmann, H.
Schroeter, M.
Hagenacker, T.
Mueller, D.
Sperfeld, A.
Bethke, F.
Drory, V.
Algom, A.
Yarnitsky, D.
Murinson, B.
Di Muzio, A.
Ciccocioppo, F.
Sorbi, S.
Mata, S.
Schenone, A.
Grandis, M.
Lauria, G.
Cazzato, D.
Antonini, G.
Morino, S.
Cocito, D.
Zibetti, M.
Yokota, T.
Ohkubo, T.
Kanda, T.
Kawai, M.
Kaida, K.
Onoue, H.
Kuwabara, S.
Mori, M.
Iijima, M.
Ohyama, K.
Baba, M.
Tomiyama, M.
Nishiyama, K.
Akutsu, T.
Yokoyama, K.
Kanai, K.
van Schaik, I. N.
Eftimov, F.
Notermans, N. C.
Visser, N.
Faber, C.
Hoeijmakers, J.
Rejdak, K.
Chyrchel-Paszkiewicz, U.
Casanovas Pons, C.
Alberti Aguiló, M.
Gamez, J.
Figueras, M.
Marquez Infante, C.
Benitez Rivero, S.
Lunn, M.
Morrow, J.
Gosal, D.
Lavin, T.
Melamed, I.
Testori, A.
Ajroud-Driss, S.
Menichella, D.
Simpson, E.
Chi-Ho Lai, E.
Dimachkie, M.
Barohn, R. J.
Beydoun, S.
Johl, H.
Lange, D.
Shtilbans, A.
Muley, S.
Ladha, S.
Freimer, M.
Kissel, J.
Latov, N.
Chin, R.
Ubogu, E.
Mumfrey, S.
Rao, T.
MacDonald, P.
Sharma, K.
Gonzalez, G.
Allen, J.
Walk, D.
Hobson-Webb, L.
Gable, K.

January 2018

Background Approximately two-thirds of patients with chronic inflammatory demyelinating polyneuropat...

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH) : a randomised, double-blind, placebo-controlled, phase 3 trial

van Schaik, Ivo N
Bril, Vera
van Geloven, Nan
Hartung, Hans-Peter
Lewis, Richard A
Sobue, Gen
Lawo, John-Philip
Praus, Michaela
Mielke, Orell
Durn, Billie L
Cornblath, David R
Merkies, Ingemar S J

January 2018

Background Approximately two-thirds of patients with chronic inflammatory demyelinating polyneuropat...

INTRAVENOUS IMMUNOGLOBULIN (IVIG) FOR RESTABILIZATION TREATMENT AFTER IVIG WITHDRAWAL IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP). RESULTS FROM THE PRE-RANDOMIZATION PHASE OF THE PATH STUDY

Mielke, O.
Bril, V.
Geloven, N. van
Hartung, H.P.
Lewis, R.A.
Sobue, G.
Lawo, J.P.
Durn, B.L.
Cornblath, D.R.
Merkies, I.S.J.
Schaik, I.N. van
PATH Study Grp

September 2017

Development and application of statistical models for medical scientific researc

Patient-reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy:the PATH study

Hartung, H. P.
Mallick, R.
Bril, V.
Lewis, R. A.
Sobue, G.
Lawo, J. P.
Mielke, O.
Durn, B. L.
Cornblath, D. R.
Merkies, I. S. J.
van Schaik, I. N.

January 2020

Background and purpose Chronic inflammatory demyelinating polyneuropathy (CIDP) causes weakness whic...

Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective

Dario Cocito
Erdita Peci
Maria Claudia Torrieri
Marinella Clerico

November 2023

The therapeutic administration of subcutaneous immunoglobulin (SCIg) offers various advantages over ...

Individualized immunoglobulin therapy in chronic immune-mediated peripheral neuropathies

Allen, Jeffrey A.
Berger, Melvin
Querol, Luis
Kuitwaard, Krista
Hadden, Robert D.
Universitat Autònoma de Barcelona

Despite the well-recognized importance of immunoglobulin therapy individualization during the treatm...

Optimizing chronic inflammatory demyelinating polyneuropathy care with subcutaneous immunoglobulin: The Polyneuropathy and Treatment with Hizentra Open-Label Extension (PATH OLE) study and beyond

Mazen M. Dimachkie

June 2022

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous, acquired autoimmune neu...

Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy

Min-Suk Yoon
Andrew Chan
Ralf Gold

May 2011

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated polyradicul...

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study

Abstract

Extracted data

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study

Abstract

Extracted data

Related items

Related items